1996
DOI: 10.1007/bf02066496
|View full text |Cite
|
Sign up to set email alerts
|

The production of interleukin-1α immunoreactivity by human oviductal cells in a coculture system

Abstract: These data showed that human oviductal cells produced interleukin-1 alpha immunoreactivity in a coculture system. However, this production could not be used as a marker for successful embryo implantation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
8
0

Year Published

2000
2000
2013
2013

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 12 publications
(8 citation statements)
references
References 13 publications
0
8
0
Order By: Relevance
“…Studies in humans as well as in animal models demonstrate that co-culture of oviductal epithelial monolayers with preimplantation embryos of the same species improves fertilization and quality of the inner cell mass, increases total embryo cell numbers and improves implantation rates (Bongso et al , 1992; Kervancioglu et al , 1997; Vlad, Walker, and Kennedy, 1996; Yeung et al , 1996; Yeung et al , 1992). Clinically, assisted reproduction technology such as IVF–embryo transfer and intracytoplasmic sperm injection have enabled bypassing the oviduct for conception with tubal factor infertility and severe male factor infertility, respectively (Palermo et al , 1992).…”
Section: Introductionmentioning
confidence: 99%
“…Studies in humans as well as in animal models demonstrate that co-culture of oviductal epithelial monolayers with preimplantation embryos of the same species improves fertilization and quality of the inner cell mass, increases total embryo cell numbers and improves implantation rates (Bongso et al , 1992; Kervancioglu et al , 1997; Vlad, Walker, and Kennedy, 1996; Yeung et al , 1996; Yeung et al , 1992). Clinically, assisted reproduction technology such as IVF–embryo transfer and intracytoplasmic sperm injection have enabled bypassing the oviduct for conception with tubal factor infertility and severe male factor infertility, respectively (Palermo et al , 1992).…”
Section: Introductionmentioning
confidence: 99%
“…Evidence is accumulating that interaction exists between the embryo and the female reproductive tract before implantation [Downing et al, 2002;Lee et al, 2002;Wolf et al, 2003]. This interaction can be achieved via the paracrine growth factors (reviewed in [Hardy and Spanos, 2002]) and/or cytokines including interleukin-1 alpha [Yeung et al, 1996], insulin-like growth factor-binding proteins [Lai et al, 1996;Watson et al, 1999], vascular endothelial growth factor and receptors [Gabler et al, 1999], transforming growth factor-b , platelet-activating factor [Downing et al, 2002], embryotrophic factors (ETFs) [Mermillod et al, 1993;Liu et al, 1995;Yeung et al, 2002;Lee et al, 2004], and other factor/peptide of unknown identity .…”
mentioning
confidence: 99%
“…2005). Studies in other species suggest that this interaction between gametes or embryos and oviduct can be achieved via the paracrine action of growth factors and/or cytokines including IL‐1α (Yeung et al. 1996), insulin‐like growth factor‐binding proteins (IGFBPs; Lai et al.…”
Section: Pre‐ and Post‐conception Periodmentioning
confidence: 99%
“…T reg -T regulatory cells, NK -natural killer cells, AA -arterio-arterial anastomoses connecting uterine and ovarian arteries (modified from Kaczmarek et al 2010) Recognition of gametes, seminal plasma components and embryos in the oviduct Gametes and embryos modulate the gene expression pattern and function of the oviduct (Georgiou et al 2005). Studies in other species suggest that this interaction between gametes or embryos and oviduct can be achieved via the paracrine action of growth factors and ⁄ or cytokines including IL-1a (Yeung et al 1996), insulin-like growth factor-binding proteins (IGFBPs; Lai et al 1996;Watson et al 1999), vascular endothelial growth factor (VEGF) and its receptors (Gabler et al 1999), TGFb (Chow et al 2001), platelet-activating factor (Downing et al 2002), embryotrophic factors (ETFs) (McCauley et al 2003) and other factors ⁄ peptides of unknown identity (Bauersachs et al 2003).…”
Section: Pre-and Post-conception Periodmentioning
confidence: 99%